BioDlink International Company Limited (HKG:1875)
Hong Kong
· Delayed Price · Currency is HKD 4.050
-0.020 (-0.49%)
Mar 10, 2026, 4:08 PM HKT
HKG:1875 Revenue
BioDlink International Company had revenue of 489.14M CNY in the half year ending June 30, 2025, with 49.10% growth. This brings the company's revenue in the last twelve months to 1.07B, up 9.63% year-over-year. In the year 2024, BioDlink International Company had annual revenue of 1.10B with 40.70% growth.
Revenue (ttm)
1.07B CNY
Revenue Growth
+9.63%
P/S Ratio
2.69
Revenue / Employee
1.77M CNY
Employees
604
Market Cap
3.15B HKD
Revenue Chart
* This company reports financials in CNY.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Medtide | 546.29M |
| SinoMab BioScience | 6.28M |
| AIM Vaccine | 1.38B |
| Antengene Corporation | 92.43M |
| Jiangsu Recbio Technology | 31.90M |
| Clover Biopharmaceuticals | 56.73M |
| Qyuns Therapeutics | 351.04M |
| TYK Medicines | 117.25K |